
apr pm et
summari global medic devic manufactur leadership posit pacemak defibril
orthoped diabet manag medic market
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
apr stock trade
look fy apr sale account
divestitur medic suppli unit
includ fx benefit rise
modestli billion billion
fy segment look largest
unit cardiac vascular sale
formerli covidien declin
restor therapi grow
diabet group declin expect
emerg market sale increas
high-singl digit account
sale see fy gross margin
basi point bp
oper margin bp
juli sold medic suppli unit
januari
complet acquisit covidien plc
think combin make
strateg sens compani product
complementari focus
cardiovascular orthoped covidien
endomechan instrument
stapl sutur minim invas
surgeri move corpor
headquart ireland due lower
corpor tax rate vs
see fy ep
posit view sale medic
suppli unit initi part
covidien acquisit unit slower
growth potenti lower margin think
covidien acquisit expand
global reach diversifi product line
make market leader numer
market think signific presenc
emerg market particularli china latin
america like drive growth higher
emerg market account
sale fasting-grow region
sale growth low mid teen
also commit invest
increment billion
next decad share trade
forward ep estim
peer near mid-point
recent five-year rang
risk opinion target price includ
loss share key market fda reject
key product weak
target price
forward ep estim line
risk assess reflect exposur intens
competit area medic equip market
typic character rel short
product life cycl price pressur threat
new market entrant howev think potenti
neg off-set mani competit
advantag scale oper sale
forc product breadth see financi
may ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview lead posit medic devic categori includ cardiac
rhythm manag spinal vascular neurolog cardiac surgeri compani acquir covidien plc
januari billion
compani oper follow segment cardiac vascular group minim invas
group restor therapi group diabet group
cardiac rhythm heart failur diseas manag divis develop manufactur market
product diagnosi treatment manag heart rhythm disord heart failur
compani product includ implant devic lead deliveri system product treatment
atrial fibril af product design reduc surgic site infect inform system
manag patient crhf devic integr health solut busi follow
princip product servic offer crhf divis
implant cardiac pacemak pacemak compani latest gener pacemak system
advisa revo mri surescan model receiv unit state food drug
administr fda approv advisa ensura mri surescan model well
micratranscathet pace receiv conformit europeen ce mark approv
implant cardiovert defibril compani latest gener evera mri
surescan first system ce mark approv full-bodi mri scan
implant cardiac resynchron therapi devic crt-d crt-p compani crt-d
viva/brava famili attain performa quadripolar lead featur new algorithm call
adaptivcrt improv heart failur patient respons rate crt-d therapi
minim invas therapi group formerli covidien consist surgic solut surgic
surgic solut develop manufactur market product therapi treat diseas
condit typic address surgeon addit compani develop manufactur
market product field minim invas gastrointestin diagnost ablat
intervent lung follow princip product offer surgic solut divis
surgic innov busi includ sale stapl vessel seal fixat hernia mechan
devic mesh hardwar surgic instrument sutur electrosurgeri product advanc
surgic product includ tri-stapl technolog platform endoscop stapl includ endo
gia reload reinforc reload tri-stapl technolog endo gia ultra univers stapler
idriv power stapl system ligasur vessel seal system multifunct laparoscop
instrument use forcetriad sonicis cordless ultrason dissect system absorbatack
absorb mesh fixat devic hernia repair symbotex composit mesh surgic laparoscop
open ventral hernia repair parietex progrip selfgrip biocompat solut inguin
restor therapi group includ spine neuromodul spine divis develop
manufactur market line medic devic implant use treatment spine
musculoskelet system compani product therapi treat variou condit affect
spine includ degen disc diseas spinal deform spinal tumor fractur spine
stenosi spine divis also provid biolog solut orthoped dental market
concert surgic technolog busi compani offer uniqu highli differenti
navig neuromonitor power technolog design spine procedur neuromodul
divis includ implant neurostimul target drug deliveri system manag
chronic pain common movement disord spastic urolog gastrointestin disord
neurostimul use implant medic devic similar pacemak call neurostimul
diabet group consist three divis intens insulin manag non-intens diabet
therapi diabet servic solut develop manufactur market advanc
integr diabet manag solut includ insulin pump therapi continu glucos
monitor cgm system therapi manag softwar
senior vice presid
chairman chief
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu
neutral sinc april technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
procedur inpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
 composit index year
date april health
declin composit index
fundament outlook health care
equip sub-industri next month
posit continu view mani product
categori histor recession-resist
expect continu grow growth
procedur rate area view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped steadili improv
see continu recoveri
medic devic tax requir
healthcar reform law went effect
januari temporarili suspend
januari
congress pass stopgap measur includ
suspend medic devic tax anoth
two year tax
slate becom effect januari
decemb congress pass tax cut
job act includ repeal
individu mandat compon
afford act requir
peopl health insur pay fine
effect januari believ repeal
individu mandat result fewer
insur peopl neg impact
equip sub-industri fewer insur
patient would like lead fewer procedur
anticip hospit
largest buyer medic equip would also
advers impact could
pressur sub-industri
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
pressur lower demand certain product
categori affect sale growth also think
 hospit becom cautiou
regard capit budget amid shift
base index
five-year market price perform apr
note sector sub-industri inform base
past perform indic futur perform
reli upon
becton dickinson compani
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
keep target line peer
forward ep estim jan-q ep vs
view lower-than-expect margin oper margin fell
bp yet encourag broad-bas growth cardiac vascular
sale rose aid new evolut transcathet aortic valv tav
see tav market among fastest grow encourag
uptak evolut minim invas sale rose pro forma
restor therapi diabet group rose /jeffrey loo cfa
et cfra keep buy opinion share plc
keep target in-lin peer
forward ep estim oct-q ep vs
view lower fy april fy ep estim
sale account divestitur fell
rose pro-forma basi sale driven robust sale emerg
market account sale sale broad-bas
note diabet sale limit sensor suppli constraint said
capac expans remain on-track /jeffrey loo cfa
et cfra keep buy opinion share plc
keep target in-lin peer fy
apr ep estim jul-q ep vs ahead
estim sale rose sale emerg market
account sale sale neg impact
vascular group sale rose minim invas therapi restor
therapi diabet group fell see rebound diabet amid
strong adopt cgm sensor /jeffrey loo cfa
rais target in-lin peer
fy apr ep estim set fy ep
apr-q ep vs ahead estim sale rose
emerg market sale sale growth broad-bas cardiac
vascular minim invas therapi restor therapi
diabet group encourag continu broad-bas
growth look market share gain particularli emerg market
guid fy sale ep /jeffrey loo cfa
et capit iq keep buy opinion share
medtron plc rais target
in-lin peer forward ep estim jan-q ep
vs ahead estim sale rose broad-bas
growth across geographi product line sale intern
emerg market cardiac vascular rose minim
invas therapi restor therapi diabet also
encourag continu margin improv synergi achiev
integr covidien acquisit oper margin expand
et capit iq keep buy opinion share
medtron plc lower target
in-lin peer forward ep estim oct-q ep
vs estim lower fy apr ep
sale rose growth forecast partli slower
 sale growth diabet unit due time approv
shipment minim minim system although believ
issu may impact sale next quarter believ broad product
portfolio geograph reach continu drive consist sale growth
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd
repres total revenu estim
fiscal year analyst estim earn
per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
